Double-Blind Placebo Controlled (DBPC) Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria (CIU)

被引：3

作者：

Cooke, Andrew J. ^{[1
]}

Morgan, Matt ^{[2
]}

Rogers, Laura ^{[3
]}

Huet-Adams, Beverley ^{[4
]}

Khan, David A. ^{[4
]}

机构：

[1] Univ Texas Southwestern, Dallas, TX USA

[2] Allergy Asthma & Immunol North TX, Allen, TX USA

[3] Univ Texas Southwestern, Chicago, IL USA

[4] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2013年 / 131卷 / 02期

关键词：

D O I：

10.1016/j.jaci.2012.12.1172

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：AB143 / AB143

页数：1

共 50 条

[1] Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria
Morgan, Matt
Cooke, Andrew
Rogers, Laura
Adams-Huet, Beverley
Khan, David A.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (05): : 601 - 606
[2] Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria (vol 2, pg 601, 2014)
Morgan, M.
Cooke, A.
Rogers, L.
Adams-Huet, B.
Khan, D. A.
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (06): : 823 - 823
[3] Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
Vena, Gino A.
Cassano, Nicoletta
Colombo, Delia
Pcruzzi, Elena
Pigatto, Paolo
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 705 - 709
[4] A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria
Finn, AF
Kaplan, AF
Fretwell, R
Qu, R
Long, J
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (05) : 1071 - 1078
[5] DOUBLE-BLIND, PLACEBO CONTROLLED COMPARISON OF CETIRIZINE AND TERFENADINE IN CHRONIC IDIOPATHIC URTICARIA
GO, MJT
WUITE, J
ARENDT, C
BERNHEIM, J
[J]. ACTA THERAPEUTICA, 1989, 15 (01) : 77 - 86
[6] CETIRIZINE AND ASTEMIZOLE THERAPY FOR CHRONIC IDIOPATHIC URTICARIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE TRIAL
BRENEMAN, D
BRONSKY, EA
BRUCE, S
KALIVAS, JT
KLEIN, GL
ROTH, HL
THARP, MD
TREGER, C
SOTER, N
[J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1995, 33 (02) : 192 - 198
[7] EFFICACY AND SAFETY OF OMALIZUMAB IN H1-ANTIHISTAMINE-REFRACTORY CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA: RESULTS OF A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Saini, S. S.
Bindslev-Jensen, C.
Maurer, M.
Grob, J. J.
Baskan, E. Bulbul
Bradley, M. S.
Georgiou, P.
Alpan, O.
Spector, S.
Rosen, K.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 111 (05) : A18 - A18
[8] Efficacy and Safety of Omalizumab in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU): Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial
Casale, Thomas
Maurer, Marcus
Hsieh, Hsin-Ju
Canvin, Janice
Saini, Sarbjit S.
Grattan, Clive
Gimenez-Arnau, Ana
Kaplan, Allen P.
Rosen, Karin
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB327 - AB327
[9] OXATOMIDE IN THE TREATMENT OF CHRONIC URTICARIA - A DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
PEREMANS, W
MERTENS, RLJ
MORIAS, J
CAMPAERT, H
[J]. DERMATOLOGICA, 1981, 162 (01): : 42 - 50
[10] A DOUBLE-BLIND PLACEBO CONTROLLED-STUDY OF TERFENADINE IN THE TREATMENT OF CHRONIC IDIOPATHIC URTICARIA
SALISBURY, J
BOR, S
BLAIR, C
[J]. BRITISH JOURNAL OF CLINICAL PRACTICE, 1987, 41 (08): : 859 - 861

← 1 2 3 4 5 →